• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protagenic Therapeutics, Inc. - Common Stock (NQ:PTIX)

0.7400 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Protagenic Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 22, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 22, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 21, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 11, 2024
 
Via Benzinga
News headline image
Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit
April 17, 2024
Via ACCESSWIRE
News headline image
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results
April 01, 2024
Via ACCESSWIRE
News headline image
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
March 27, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 11, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 01, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 30, 2024
 
Via Benzinga
News headline image
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket ↗
September 16, 2024
 
Via Benzinga
News headline image
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
March 25, 2024
Via ACCESSWIRE
News headline image
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
February 13, 2024
Via ACCESSWIRE
News headline image
Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
September 26, 2023
Via ACCESSWIRE
News headline image
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗
September 12, 2024
 
Via Benzinga
News headline image
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q2 2024 ↗
August 15, 2024
Protagenic Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q1 2024 ↗
June 25, 2024
Protagenic Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
May 23, 2024
 
Via Benzinga
News headline image
Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders
May 22, 2024
Via ACCESSWIRE
News headline image
Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial
May 01, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
April 26, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
April 25, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
April 23, 2024
 
Via Benzinga
News headline image
PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q4 2023 ↗
April 01, 2024
Protagenic Therapeutics just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For April 1, 2024 ↗
April 01, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
News headline image
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
March 21, 2024
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
March 05, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
December 13, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 10, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 04, 2023
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap